Revenue: As of FY2026 Q2, the actual value is USD 340.1 M.

EPS: As of FY2026 Q2, the actual value is USD 0.05.

EBIT: As of FY2026 Q2, the actual value is USD 1.289 M.

Second Quarter 2026 Financial Highlights

Gross Profit and Margin

Gross profit for the second quarter of 2026 was $169.9 million, with a gross profit margin of 50%, an increase of 70 basis points year-over-year. On an adjusted basis, gross profit from continuing operations was $170.8 million, and adjusted gross profit margin was 50.2%, an increase of 60 basis points compared to 49.6% in the prior-year period.

Net Income

Net income attributable to Curaleaf Holdings, Inc. from continuing operations was $12.5 million for the second quarter of 2026. The total net income was $12.507 million.

Adjusted EBITDA and Margin

Adjusted EBITDA was $70.1 million, and the adjusted EBITDA margin was 20.6% for the second quarter of 2026, which is a 120 basis point decrease year-over-year.

Operating Expenses

Selling, general and administrative expenses were $131.677 million. Depreciation and amortization as an operating expense totaled $34.015 million. Total operating expenses amounted to $165.692 million.

Income from Continuing Operations

Income from continuing operations was $4.222 million.

Other Income/Expense

Net other expense was - $30.530 million.

Loss Before Income Taxes

Loss before benefit for income taxes was - $26.308 million.

Benefit for Income Taxes

Benefit for income taxes was $38.784 million.

Net Income (Loss) from Discontinued Operations

Net income from discontinued operations was $31 thousand.

Cash and Debt

As of June 30, 2026, Curaleaf Holdings, Inc. had $107.0 million in cash and cash equivalents and $611.5 million in outstanding debt, net of unamortized debt discounts and deferred financing fees.

Six Months Ended June 30, 2026 Financial Highlights

Gross Profit and Margin

Gross profit for the six months ended June 30, 2026, was $327.2 million, with a gross margin of 49%, a decrease of 80 basis points year-over-year. On an adjusted basis, gross profit from continuing operations was $327.9 million, and adjusted gross profit margin was 49.4%, a decrease of 80 basis points compared to 50.2% in the prior-year period.

Net Income

Net income attributable to Curaleaf Holdings, Inc. from continuing operations was $82.6 million. The total net income was $82.290 million.

Adjusted EBITDA and Margin

Adjusted EBITDA was $133.5 million, and the adjusted EBITDA margin was 20.1%, a 100 basis point decrease year-over-year.

Operating Expenses

Selling, general and administrative expenses were $254.547 million. Depreciation and amortization as an operating expense totaled $67.682 million. Total operating expenses amounted to $322.229 million.

Income from Continuing Operations

Income from continuing operations was $4.975 million.

Other Income/Expense

Net other expense was - $59.912 million.

Loss Before Income Taxes

Loss before benefit for income taxes was - $54.937 million.

Benefit for Income Taxes

Benefit for income taxes was $137.489 million.

Net Income (Loss) from Discontinued Operations

Net loss from discontinued operations was - $262 thousand.

Cash Flow

Net cash provided by operating activities from continuing operations for the six months ended June 30, 2026, was $50.305 million. Purchases of property, plant and equipment, net of disposals, were - $32.915 million, resulting in free cash flow from continuing operations of $17.390 million.

Capital Expenditures

Curaleaf Holdings, Inc. invested $32.9 million in capital expenditures during the six months ended June 30, 2026.

Share Repurchases

Curaleaf Holdings, Inc. retired and repurchased 1.01 million shares for a total value of $7.4 million during the six months ended June 30, 2026.

Segment Revenue (Three Months Ended June 30, 2026)

Domestic Operations

Domestic retail revenue was $224.378 million, wholesale revenue was $64.046 million, and management fee income was $271 thousand, totaling $288.695 million in net domestic revenues.

International Operations

International retail revenue was $16.353 million, wholesale revenue was $31.947 million, and management fee income was $3.104 million, totaling $51.404 million in net international revenues.

Segment Revenue (Six Months Ended June 30, 2026)

Domestic Operations

Domestic retail revenue was $439.601 million, wholesale revenue was $125.562 million, and management fee income was $519 thousand, totaling $565.682 million in net domestic revenues.

International Operations

International retail revenue was $32.238 million, wholesale revenue was $60.233 million, and management fee income was $6.177 million, totaling $98.648 million in net international revenues.

Operational Metrics and Highlights

Curaleaf Holdings, Inc. expanded its retail footprint in Florida to 73 dispensaries, bringing the nationwide total to 174 operated and managed dispensaries. The company launched Dark Heart, its ultra-premium flower brand, across 11 states. Curaleaf Holdings, Inc. also completed the buyout of the remaining 45% equity interest in Four20 Pharma, increasing its ownership of Curaleaf International to 100%.

Outlook

Chairman and CEO Boris Jordan stated that the second quarter results reinforce that the ‘Built for Growth’ strategy is gaining traction, with both domestic and international segments contributing to growth. He noted that the U.S. business has regained momentum, marking the second consecutive quarter of domestic year-over-year growth. Jordan expressed confidence in the team, strategy, and operating discipline to lead the next phase of cannabis, aiming to make Curaleaf Holdings, Inc. the global leader in cannabis.